Work

SAT-029 Haemodialysis in Fiji

Year: 2019

Type: conference-abstract

Abstract: Fiji has a high rate of end-stage kidney disease (ESKD), estimated at 750-938 per million population (pmp), with chronic kidney disease currently the fourth leading cause of death. While haemodialysis (HD) is available as the primary form of renal replacement therapy (RRT), access is limited to those who can afford it. Currently no unified process for data collection regarding ESKD treatments and outcomes exists. We aim to describe the dialysis population in Fiji and document important clinical outcomes.

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2019.05.051

Authors: B. TALBOT, L. Kumar, S. Sen, S. Jesudason, M. Gallagher, A. Krishnan, J. Malani, D. Wilson, A. Ritchie

Institutions: UNSW Sydney, The George Institute for Global Health, Fiji National University, The University of Sydney, Concord Repatriation General Hospital, Royal Adelaide Hospital, The University of Adelaide, Colonial War Memorial Hospital

Language: English

Topic: Dialysis and Renal Disease Management

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,625

OpenAlex ID: W2955111964

Cites:

Cited by:

Related to: 10